If you or a loved one have been struggling with depression that hasn’t responded to traditional treatments, there’s new hope on the horizon. Georgia Behavioral Health is proud to offer Spravato (esketamine), a groundbreaking medication that’s transforming the landscape of mental health care.

Spravato is administered as a nasal spray in a controlled clinical setting. It’s typically used in conjunction with an oral antidepressant. The treatment protocol involves a series of initial doses, followed by maintenance doses as needed.

While the exact way Spravato works is still being studied, it’s believed to rapidly restore connections between brain cells, leading to improvements in mood and cognition. Many individuals experience significant symptom relief within hours or days of their first dose.